SANUWAVE Health, Inc. (SNWV)
NASDAQ: SNWV · Real-Time Price · USD
33.68
+0.68 (2.06%)
Jun 20, 2025, 4:00 PM - Market closed
SANUWAVE Health Income Statement
Financials in millions USD. Fiscal year is January - December.
Millions USD. Fiscal year is Jan - Dec.
Fiscal Year | TTM | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | 2015 - 2019 |
|---|---|---|---|---|---|---|---|
Period Ending | Mar '25 Mar 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | Dec '20 Dec 31, 2020 | 2015 - 2019 |
| Operating Revenue | 36.19 | 32.63 | 20.4 | 16.74 | 13.01 | 4.06 | Upgrade
|
| Revenue | 36.19 | 32.63 | 20.4 | 16.74 | 13.01 | 4.06 | Upgrade
|
| Revenue Growth (YoY) | 61.50% | 59.99% | 21.84% | 28.69% | 220.68% | 294.37% | Upgrade
|
| Cost of Revenue | 8.46 | 8.08 | 6.04 | 4.33 | 4.99 | 1.16 | Upgrade
|
| Gross Profit | 27.73 | 24.55 | 14.36 | 12.41 | 8.02 | 2.9 | Upgrade
|
| Selling, General & Admin | 18.76 | 17.67 | 13.57 | 20.03 | 20.28 | 17.78 | Upgrade
|
| Research & Development | 0.72 | 0.67 | 0.58 | 0.57 | 1.1 | 1.25 | Upgrade
|
| Operating Expenses | 20.28 | 19.13 | 14.9 | 21.36 | 22.17 | 19.81 | Upgrade
|
| Operating Income | 7.45 | 5.42 | -0.54 | -8.95 | -14.14 | -16.92 | Upgrade
|
| Interest Expense | -11.93 | -13.64 | -15.62 | -14.13 | -7.1 | -2.54 | Upgrade
|
| Currency Exchange Gain (Loss) | - | - | - | - | -0 | -0.04 | Upgrade
|
| Other Non Operating Income (Expenses) | -34.45 | -29.45 | -9.64 | 16.65 | -2.62 | -2.59 | Upgrade
|
| EBT Excluding Unusual Items | -38.92 | -37.67 | -25.8 | -6.44 | -23.86 | -22.09 | Upgrade
|
| Merger & Restructuring Charges | - | - | - | - | - | -1.1 | Upgrade
|
| Asset Writedown | - | - | - | - | - | -7.19 | Upgrade
|
| Other Unusual Items | 6.43 | 6.33 | - | -3.85 | -3.37 | -0.57 | Upgrade
|
| Pretax Income | -32.49 | -31.35 | -25.8 | -10.29 | -27.23 | -30.94 | Upgrade
|
| Income Tax Expense | 0.03 | 0.03 | 0 | 0 | 0.03 | - | Upgrade
|
| Net Income | -32.52 | -31.37 | -25.81 | -10.29 | -27.26 | -30.94 | Upgrade
|
| Net Income to Common | -32.52 | -31.37 | -25.81 | -10.29 | -27.26 | -30.94 | Upgrade
|
| Shares Outstanding (Basic) | 6 | 4 | 2 | 1 | 1 | 1 | Upgrade
|
| Shares Outstanding (Diluted) | 6 | 4 | 2 | 1 | 1 | 1 | Upgrade
|
| Shares Change (YoY) | 132.22% | 110.82% | 44.47% | 6.00% | 37.08% | 85.73% | Upgrade
|
| EPS (Basic) | -5.58 | -7.03 | -12.19 | -7.02 | -19.72 | -30.68 | Upgrade
|
| EPS (Diluted) | -5.58 | -7.03 | -12.19 | -7.50 | -19.72 | -30.68 | Upgrade
|
| Free Cash Flow | -0.7 | 1.97 | -4.54 | -17.17 | -6.94 | -12.77 | Upgrade
|
| Free Cash Flow Per Share | -0.12 | 0.44 | -2.14 | -11.72 | -5.02 | -12.66 | Upgrade
|
| Gross Margin | 76.63% | 75.23% | 70.41% | 74.13% | 61.68% | 71.36% | Upgrade
|
| Operating Margin | 20.59% | 16.60% | -2.65% | -53.47% | -108.70% | -416.93% | Upgrade
|
| Profit Margin | -89.86% | -96.13% | -126.52% | -61.48% | -209.52% | -762.56% | Upgrade
|
| Free Cash Flow Margin | -1.93% | 6.02% | -22.25% | -102.55% | -53.33% | -314.79% | Upgrade
|
| EBITDA | 8.67 | 6.56 | 0.49 | -8 | -12.91 | -15.9 | Upgrade
|
| EBITDA Margin | 23.96% | 20.11% | 2.39% | -47.78% | -99.20% | - | Upgrade
|
| D&A For EBITDA | 1.22 | 1.15 | 1.03 | 0.95 | 1.24 | 1.01 | Upgrade
|
| EBIT | 7.45 | 5.42 | -0.54 | -8.95 | -14.14 | -16.92 | Upgrade
|
| EBIT Margin | 20.59% | 16.60% | -2.65% | -53.47% | -108.70% | - | Upgrade
|
| Revenue as Reported | - | - | - | - | - | 4.06 | Upgrade
|
Updated Mar 20, 2025. Source: S&P Global Market Intelligence. Standard template. Financial Sources.